Known as Breast Circulating Methylation Assay (BCMA), the new blood test looks for tumour DNA released into the bloodstream ...
GlobalData on MSN
Roche gains CE Mark for bacterial vaginosis/candida vaginitis assay
Roche has secured CE Mark approval for its cobas BV/CV assay to support the diagnosis of infectious causes of vaginitis.
The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...
Potentially any day now, the US Food and Drug Administration (FDA) will rule on a request which – if granted – will boost ...
The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...
Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces the commercial launch of QAPs™ quality assessment products and ...
IsoPSA is a blood assay that detects variations of the PSA protein that signal a higher likelihood of high-grade tumors. It ...
New test shows high sensitivity for tuberculosis, providing a faster, near-point-of-care option for early detection and ...
British scientists have developed a pioneering blood test to boost survival chances by quickly identifying breast cancer ...
Plus Therapeutics (PSTV)’ wholly-owned subsidiary CNSide Diagnostics has been granted lab licenses to provide the CNSide Cerebrospinal Fluid Tumor ...
Making HPV Tests & Quality Assessment Products Available across Mexico. MISSISSAUGA, Ontario and MEXICO CITY, Dec. 03, 2025 ...
Basel, 9 December 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the CE Mark for its cobas® BV/CV (Bacterial Vaginosis/Candida Vaginitis) assay to accurately identify specific bacteria and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results